Company / Free Cash Flow per Share
NovoCure Ltd Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$0.70
FY2025
5-year range
-$0.96 / $0.57
FY2021-FY2025
Trend
-7.9%
vs FY2024
Sector context
#125 of 142
Health Care
What the data says
NovoCure Ltd's free cash flow per share of $-0.70 is lower than 88% of companies in the Health Care sector (FY2025). Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $-1.35 in FY2016 to $0.85 in FY2020.
Based on SEC 10-K filings.
-0.70 in FY2025.
Improved from $-0.96 to $-0.70 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 142This company -$0.70 Sector average $5.16
▼
-113.5% below sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 7.9% year-over-year.
- Ranks #125 out of 142 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2020.
- Lowest free cash flow per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.70 | -7.9% |
| FY2024 | -$0.65 | +32.4% |
| FY2023 | -$0.96 | -1154.1% |
| FY2022 | $0.09 | -84.2% |
| FY2021 | $0.57 | -32.3% |
| FY2020 | $0.85 | +388.8% |
| FY2019 | $0.17 | +280.5% |
| FY2018 | -$0.10 | +79.4% |
| FY2017 | -$0.47 | +65.6% |
| FY2016 | -$1.35 | +82.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026